Excited to experience the thrill of Mahakumbh that comes once in 144 years? Here is an expert guide for all must-have essentials to pack for your trip.

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Shows tariffs' share of total government revenue "Tariffs are going to be a really important part of the tax-cut discussion." A 10% tariff is "about $350 to $400 billion in revenue. So you see the ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

On Tuesday, the Food and Drug Administration (FDA) approved Johnson & Johnson’s nasal spray, Spravato (esketamine), to treat major depressive disorder. Oral antidepressants are the most common ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

On January 21, 2025, New York State Governor Kathy Hochul announced some highlights of the 2026 Fiscal Year Executive Budget. The budget will include over $5 billion in tax cuts, credits, and refunds ...

For the Army to avoid big cuts while still meeting Pentagon objectives in the Pacific, DOD would need a roughly 10% annual budget increase, the report said. Overall, Dahmer’s report recommends ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...